1992
DOI: 10.1016/0047-6374(92)90137-3
|View full text |Cite
|
Sign up to set email alerts
|

Homeostasis between lipid peroxidation and antioxidant enzyme activities in healthy human aging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
43
1

Year Published

1995
1995
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 86 publications
(49 citation statements)
references
References 15 publications
5
43
1
Order By: Relevance
“…Both overall and abdominal obesity 16 have been said to increase LDL oxidizability. In addition, age may 17 or may not 18 have this same effect. Consequently, we performed multiple regression analysis to determine whether any of these factors could affect LDL oxidation status independently of insulin resistance or its metabolic covariates.…”
Section: Resultsmentioning
confidence: 99%
“…Both overall and abdominal obesity 16 have been said to increase LDL oxidizability. In addition, age may 17 or may not 18 have this same effect. Consequently, we performed multiple regression analysis to determine whether any of these factors could affect LDL oxidation status independently of insulin resistance or its metabolic covariates.…”
Section: Resultsmentioning
confidence: 99%
“…Inhibition of plasma lipid peroxidation in blood plasma was determined according to the method developed by Rodriguez-Martinez and Ruiz-Torres (1992). Plasma (400 µL), 100 µL of FeSO 4 .7H 2 O solution (500 µM), 100 µL of H 2 O 2 (500 µM), and 200 µL of Fe@Au nanospheres (2 mg/mL) were mixed and incubated for 12 h at 37 °C.…”
Section: Inhibition Of Plasma Lipid Peroxidationmentioning
confidence: 99%
“…The mixture was stirred vigorously, kept at 95 °C for 30 min, and then cooled. Following that process, 1-butanol was added to the mixture at a 1:1 ratio and the absorbance was measured at 532 nm (Rodriguez-Martinez and Ruiz-Torres, 1992 …”
Section: Inhibition Of Plasma Lipid Peroxidationmentioning
confidence: 99%
“…MDA has also been extensively used as a marker of lipid peroxi dation mainly in processes associated with oxidative stress and vascular injury. Thus, high levels of MDA have been detected in plasma or vascular tissue in either aging [3,13,14] or diseases associated with vascular damage [15], such as diabetes [16][17][18], hypertension [20,21], or atherosclerosis [22,23], A common finding in these dis eases, as well as in aging, is the impairment of endothe lium-dependent relaxations, especially those evoked by acetylcholine (ACh) [24][25][26][27][28], Despite these data, there are no studies, to our knowledge, that analyze whether MDA may interfere with endothelium-dependent relaxations. If this occurs it could justify, at least in part, the reduction of these relaxations in the above-mentioned processes.…”
Section: Introductionmentioning
confidence: 99%
“…Lipid peroxidation and peroxidation products are the focus of intense current interest in biomedical and phar macological research since they play an important role in the pathogenesis of several clinically significant diseases [1,2], as well as in the physiological changes associated with aging process [3], Lipid peroxidation may be pro duced: (a) in a nonenzymatic manner, in which polyunsat urated fatty acids (PUFA) oxygenation can be induced by oxygen-derived free radicals and transition metals [4,5], and (b) in an enzymatic manner, in which PUFA oxygen ation leads to synthesis of the collectively termed eicosanoids [6,7], Malondialdehyde (MDA) is formed as a product of either the nonenzymatic lipid oxidation or enzymatic arachidonic acid oxygenation in the cyclooxy genase pathway [8], Thus, thromboxane synthase con verts prostaglandin H2 into thromboxane A2, heptadecatrienoic acid and MDA in equimolar amounts [9].…”
Section: Introductionmentioning
confidence: 99%